Effect of inhibition of aldose reductase on glucose flux, diacylglycerol formation, protein kinase C, and phospholipase A2 activation

Metabolism: Clinical and Experimental

Volumn 46, Issue 1, 1997, Pages 41-47

  Keogh, Rosemary J ^a   Dunlop, Marjorie E ^a   Larkins, Richard G ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE REDUCTASE; ARACHIDONIC ACID; DIACYLGLYCEROL; GLUCOSE; IMIRESTAT; PHOSPHOLIPASE A2; POLYOL; PROSTAGLANDIN E; PROTEIN KINASE C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ENZYME INHIBITION; GLOMERULUS; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HYPERGLYCEMIA; MALE; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PENTOSE PHOSPHATE CYCLE; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RAT;

EID: 0031037415     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(97)90165-7     Document Type: Article

References (51)

1. Ayo SH, Radnik RA, Glass WR II, et al: Increased extracellular matrix synthesis and mRNA in mesangial cells grown in high-glucose medium. Am J Physiol 260:F185-F191, 1991
2. Pugliese G, Pricci F, Pugliese F, et al: Mechanisms of glucose-enhanced extracellular matrix accumulation in rat glomerular mesangial cells. Diabetes 43:478-490, 1994
3. Cohen MP, Khalifa A: Renal glomerular collagen synthesis in streptozotocin diabetes. Reversal of increased basement membrane synthesis with insulin therapy. Biochim Biophys Acta 500:395-404, 1977
4. Brownlee M, Vlassara H, Cerami A: Nonenzymatic glycosylation and the pathogenesis of diabetic complications. Ann Intern Med 101:527-537, 1984
5. McLennan SV, Fisher EJ, Yue DK, et al: High glucose concentration causes a decrease in mesangium degradation. A factor in the pathogenesis of diabetic nephropathy. Diabetes 43:1041-1045, 1995
6. Sato Y, Hotta N, Sakamoto N, et al: Lipid peroxide level in plasma of diabetic patients. Biochem Med 21:104-107, 1976
7. Crouch R, Kimsey G, Priest DG, et al: Effect of streptozotocin on erythrocyte and retinal Superoxide dismutase. Diabetologia 15:53-57, 1978
8. Loven DP, Schedl HP, Oberley LW, et al: Superoxide dismutase activity in the intestine of the streptozotocin-diabetic rat. Endocrinology 111:737-742, 1982
9. Matkovics B, Varga SI, Szabo L, et al: The effect of diabetes on the activities of the peroxide metabolism enzymes. Horm Metab Res 14:77-79, 1982
10. Larkins RG, Dunlop ME: The link between hyperglycaemia and diabetic nephropathy. Diabetologia 35:499-504, 1992
11. DeRubertis FR, Craven PA: Activation of protein kinase C in glomerular cells in diabetes. Diabetes 43:1-8, 1994
12. Hostetter TH, Troy JL, Brenner BM: Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int 19:410-415, 1981
13. Carney SL, Wong NLM, Dirks JH: Acute effects of streptozotocin diabetes on rat renal function. J Lab Clin Med 93:950-961, 1979
14. Mogensen CE: Glomerular filtration rate and renal plasma flow in short-term and long-term juvenile diabetes mellitus. Scand J Clin Lab Invest 28:91-100, 1971
15. Mogensen CE, Andersen MJF: Increased kidney size and glomerular filtration rate in untreated juvenile diabetes: Normalization by insulin-treatment. Diabetologia 11:221-224, 1975
16. Arima S, Ren Y, Juncos LA, et al: Glomerular prostaglandins modulate vascular reactivity of the downstream efferent arterioles. Kidney Int 45:650-658, 1994
17. Kreisberg JI, Patel PY: The effects of insulin, glucose and diabetes on prostaglandin production by rat kidney glomeruli and cultured glomerular mesangial cells. Prostaglandins Leukot Med 11:431-442, 1983
18. Schambelan M, Blake S, Sraer J, et al: Increased prostaglandin production by glomeruli isolated from rats with streptozotocin-induced diabetes mellitus. J Clin Invest 75:404-412, 1985
19. Craven PA, Caines MA, DeRubertis FR: Sequential alterations in glomerular prostaglandin and thromboxane synthesis in diabetic rats: Relationship to the hyperfiltration of early diabetes. Metabolism 36:95-103, 1987
20. DeRubertis FR, Craven PA: Eicosanoids in the pathogenesis of the functional and structural alterations of the kidney in diabetes. Am J Kidney Dis 22:727-735, 1993
21. Goldfarb S, Ziyadeh FN, Kern EFO, et al: Effects of polyolpathway inhibition and dietary myo-inositol on glomerular hemodynamic function in experimental diabetes mellitus in rats. Diabetes 40:465-471, 1991
22. Pedersen MM, Christiansen JS, Mogensen CE: Reduction of glomerular hyperfiltration in normoalbuminuric IDDM patients by 6 mo of aldose reductase inhibition. Diabetes 40:527-531, 1991
23. Craven PA, DeRubertis FR: Sorbinil suppresses glomerular prostaglandin production in the streptozotocin diabetic rat. Metabolism 38:649-654, 1989
24. Chang WP, Dimitriadis E, Allen T, et al: The effect of aldose reductase inhibitors on glomerular prostaglandin production and urinary albumin excretion in experimental diabetes mellitus. Diabetologia 34:225-231, 1991
25. Frey J, Zager P, Jackson J, et al: Aldose-reductase activity mediates renal prostaglandin production in streptozotocin diabetic rats. Kidney Int 35:292A, 1989 (abstr)
26. Sochor M, Kunjara S, McLean P: The effect of aldose reductase inhibitor statil (ICI 128436) on the glucose over-utilization in kidney of diabetic rats. Biochem Pharmacol 37:3349-3356, 1988
27. Tilton RG, Chang K, Nyengaard JR, et al: Inhibition of sorbitol dehydrogenase: Effects on vascular and neural dysfunction in streptozocin-induced diabetic rats. Diabetes 44:234-242, 1995
28. Lou MF, Dickerson JE Jr, Garadi R, et al: Glutathione depletion in the lens of galactosemic and diabetic rats. Exp Eye Res 46:517-530, 1988
29. Sochor M, Baquer NZ, McLean P: Regulation of pathways of glucose metabolism in kidney. The effect of experimental diabetes on the activity of the pentose phosphate pathway and the glucuronate-xylulose pathway. Arch Biochem Biophys 198:632-646, 1979
30. Craven PA, Davidson CM, DeRubertis FR: Increase in diacylglycerol mass in isolated glomeruli by glucose from de novo synthesis of glycerolipids. Diabetes 39:667-674, 1990
31. Craven PA, DeRubertis FR: Protein kinase C is activated in glomeruli from streptozotocin diabetic rats. J Clin Invest 83:1667-1675, 1989
32. Williams B, Schrier RW: Glucose-induced protein kinase C activity regulates arachidonic acid release and eicosanoid production by cultured glomerular mesangial cells. J Clin Invest 92:2889-2896, 1993
33. 2 by p42 microtubule-associated protein 2 kinase and protein kinase C. J Biol Chem 268:1960-1964, 1993
34. Craven PA, Patterson MC, DeRubertis FR: Role of enhanced arachidonate availability through phospholipase A2 pathway in mediation of increased prostaglandin synthesis by glomeruli from diabetic rats. Diabetes 37:429-435, 1988
35. Stevens EJ, Willars GB, Lidbury P, et al: Vasoreactivity and prostacyclin release in streptozotocin-diabetic rats: Effects of insulin or aldose reductase inhibition. Br J Pharmacol 109:980-986, 1993
36. Sener A, Malaisse WJ: A sensitive radioisotopic method for the measurement of NAD(P)H: Its application to the assay of metabolites and enzymatic activities. Anal Biochem 186:236-242, 1990
37. 2 in glucose stimulated pancreatic islets. Biochem Biophys Res Commun 120:820-827, 1984
38. Dunlop M, Keogh R, Larkins RG: Fibronectin-induced increase in mesangial cell prostaglandin release. Diabetes 42:183-190, 1993
39. 2 is coupled to hormonally regulated release of arachidonic acid. Proc Natl Acad Sci USA 89:6147-6151, 1992
40. 2. J Biol Chem 266:14526-14534, 1991
41. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254, 1976
42. Henry DN, Rood S, Spielman W: Heterogeneity of aldose reductase (AR) gene expression: Increased steady state abundance of AR mRNA is not due to differences in basal transcription. J Am Soc Nephrol 6:362A, 1995 (abstr)
43. Kaneko M, Carper D, Nishimura C, et al: Induction of aldose reductase expression in rat kidney mesangial cells and Chinese hamster ovary cells under hypertonic conditions. Exp Cell Res 188:135-140, 1990
44. Baynes JW: Role of oxidative stress in development of complications in diabetes. Diabetes 40:405-412, 1991
45. Grunewald RW, Weber II, Kinne-Saffran E, et al: Control of sorbitol metabolism in renal inner medulla of diabetic rats: Regulation by substrate, cosubstrate and products of the aldose reductase reaction. Biochim Biophys Acta 1225:39-47, 1993
46. 125I-albumin permeation: Roles of nitric oxide and Superoxide. FASEB J 7:A905, 1993 (abstr)
47. Tilton RG, Chang K, Faller AF: Probucol prevents vascular protein leakage induced by diabetes, glucose, and glycated proteins. Diabetes 42:89A, 1993 (suppl 1, abstr)
48. Kunisaki M, Bursell S-E, Umeda F, et al: Normalization of diacylglycerol-protein kinase C activation by vitamin E in aorta of diabetic rats and cultured rat smooth muscle cells exposed to elevated glucose levels. Diabetes 43:1372-1377, 1994
49. 2 in human umbilical vein endothelial cells cultured in high glucose medium. Diabetologia 37:264-269, 1994
50. 2. Biochem J 272:561-568, 1990
51. Mahadevan P, Larkins RG, Fraser JRE, et al: Increased hyaluronan production in the glomeruli from diabetic rats: A link between glucose-induced prostaglandin production and reduced sulphated proteoglycan. Diabetologia 38:298-305, 1995